Home Obi Profile Fees Services News Publications Contact  
You are here: Title Details
Search  
    Login
Inventions Industrial DesignTechnological Information
TREATMENT OF CANCER WITH A COMBINATION OF AN AGENT THAT PERTURBS THE EGF SIGNALING PATHWAY AND AN OLIGONUCLEOTIDE THAT REDUCES CLUSTERIN LEVELS

No-Receipt date 2014-00913 - 28/03/2014
No-Filing date 20140400598 - 28/03/2014
No-Granting date 3083103 - 31/03/2014
No-EPO application date 05810600.6 - 22/11/2005
No-EPO granting date 1814595 - 08/01/2014
Gazette No-Publication date of application -
Gazette No-Publication date of granted patent 3/2014 - 16/04/2014
Expiration date 23/11/2025
Kind of title Validation of European Patent
Legal status NOT VALID
Priorities US522948 P23/11/2004/US
US522960 P24/11/2004/US
Active Substance of Supplementary Certificates -

IPC Classification
Ipc Class
A61K 31/7088
A61K 39/395
A61K 48/00
A61P 35/00

Related Documents

Related Titles

Owners
CodeFirstnameSurnameAddressTownZIPCountry
522174 THE UNIVERSITY OF BRITISH COLUMBIA NO 103 - 6190 AGRONOMY ROADVANCOUVER, BRITISH COLUMBIA V6T 1Z3 CANADA

Inventors
CodeFirstnameSurname
1253363 GLEAVE, MARTIN
1253364 ZUPI, GABRIELLA

Representatives
CodeFirstnameSurnameAddressTownZip
3098ANNAGIAKOUMIALKAMENOUS 12-14ATHINA (ATTIKIS)10439

Contact
CodeFirstnameSurnameAddressTownZipCountry
8397ANDRONIKIMISIOUANALIPSEOS 23 KAI MARATHONOS 27VRILISSIA (ATTIKIS)15235 GREECE

Owners History

Title Instruments
DateOperationDescreption
6/12/2017 12:00:00 AMΈκπτωση Κύριων Τίτλων (79602) ΕΚΠΤΩΣΕΙΣ 05/2017 Αρ. Πρωτ. Γ.Δ. 1012 / 12.06.2017

Payments history 11 renewals have been done
Print
Dues Online PaymentNational Patent RegisterOne Stop Shop (OSS)
© OBI all rights reserved designed & developed by PROFILE S.A.
Certified QMS : EN ISO 9001:2015 and ΕΝ ISO 14001:2015